| CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
1.305 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
1.305 |
Evidence |
|
| ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
TGFA |
TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow |
1.305 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.305 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.305 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.305 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.305 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.305 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
1.305 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.305 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.305 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
BMX |
IPI00514142 |
1.305 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
1.305 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
BMX |
IPI00514142 |
1.305 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.305 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.305 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.305 |
Evidence |
|
| TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
JAK1 |
|
1.305 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.305 |
Evidence |
|
| GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.305 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.305 |
Evidence |
|
| SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
1.305 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.305 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.305 |
Evidence |
|